Genasys Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 28, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 37% |
| Jun 2, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 37% |
| Mar 13, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Mar 11, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 37% |
| Dec 22, 2025 | Ascendiant Capital | maintain | Buy → Buy | $5.25 | 37% |
| Oct 6, 2025 | Ascendiant Capital | maintain | Buy → Buy | $5.75 | 37% |
| Jun 6, 2025 | Ascendiant Capital | maintain | Buy → Buy | $5.5 | 37% |
| Dec 16, 2024 | Ascendiant Capital | maintain | Buy → Buy | $5.5 | 37% |
| Aug 19, 2024 | Ascendiant Capital | maintain | Buy → Buy | $4.75 | 37% |
| Nov 13, 2023 | Roth MKM | initiate | — → Buy | $3.5 | 52% |
| May 9, 2023 | Oppenheimer | maintain | — → Outperform | $6 | 52% |
| Feb 10, 2023 | Oppenheimer | maintain | — → Outperform | $7 | 52% |
| May 10, 2022 | Stephens & Co. | maintain | — → Overweight | $6 | 54% |
| Nov 16, 2021 | Stephens & Co. | initiate | — → Overweight | $8 | 54% |
| Oct 13, 2020 | Northland Capital Markets | initiate | — → Outperform | $7.5 | 49% |
No cross-platform signals in the last 90 days